EyePoint Pharmaceuticals Inc
Research EyePoint Pharmaceuticals Inc (EYPT) on Bullrun: market cap USD 1.18B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEYPT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.18B
- Financial periodFY2025
- RevenueUSD 31.37M
- Revenue growth-27.5%
- Net income-USD 231.96M
- Free cash flow-USD 243.39M
Valuation Snapshot
latest market cap is USD 1.18B.
About EyePoint Pharmaceuticals Inc
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery.
Frequently asked questions
What is EyePoint Pharmaceuticals Inc's market cap?
EyePoint Pharmaceuticals Inc's market capitalization is USD 1.18B.
What does EyePoint Pharmaceuticals Inc do?
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery.